Neflamapimod Shows Promise in Treating Dementia with Lewy Bodies
ELP Pharma readying plans to continue to study the drug in a phase 3 trial.
Related Articles
Guselkumab 100 mg Every 8 Weeks Consistently Improves Joint, Skin Through Week 24
The COSMOS trial showed guselkumab every 8 weeks improved PsA outcomes through week 48, including in patients with inadequate responses to TNF inhibitors.
Diabetes Dialogue: Exploring New Horizons in Incretin Therapy for Diabetes and Weight Loss
In this episode, hosts discuss the efficacy of MariTide for obesity, a head-to-head comparison of semaglutide vs. tirzepatide, and concerns about GLP-1 agonist compounding.
CagriSema Achieves 22.7% Weight Loss in Phase 3 REDEFINE 1 Trial
CagriSema, a fixed dose of cagrilintide 2.4 mg and semaglutide 2.4 mg, achieved statistically significant weight loss after 68 weeks versus placebo.
New Data Supports Liver Retransplantation for Patients with PSC Recurrence
Retransplantation outcomes were similar or better in patients with PSC compared with patients with other liver disease etiologies.
The Medical Sisterhood: Role Models and Mentorship, with Susan Taylor, MD, and Linda Stein Gold, MD
Susan Taylor, MD, and Linda Stein Gold, MD, join The Medical Sisterhood for an intimate conversation on the importance of role models and mentors.
Hyperglycemia, Obesity Relevant Risk Factors for Retinopathy in Type 1 Diabetes
Glycemic control continues to be a major risk factor for diabetic retinopathy, while overweight, obesity, and hypertension are growing in prevalence.
PSC Linked to Worse Transplant, Mortality Outcomes Than PBC, Autoimmune Hepatitis
Patients with PSC had worse death, transplant, liver-related mortality, and liver-related decompensation outcomes than PBC and autoimmune hepatitis.
FDA Approves Concizumab for Hemophilia A or B with Inhibitors
Concizumab marks the first subcutaneous injection treatment for hemophilia A or B with inhibitors, demonstrating an 86% reduction in bleeds in pivotal trial data.
Use of Ibuprofen, Other NSAIDs During Pregnancy Could Increase Risk of Childhood CKD
Gestational exposure to certain NSAIDs during different trimesters of pregnancy was associated with an increased risk of childhood CKD.
Study Highlights Comorbidities Before, After Bullous Pemphigoid Diagnosis
In this case–control study, investigators identified relevant comorbidities among individuals with bullous pemphigoid before and after their diagnoses.